2024年关于国家政策,计划和消除乙型肝炎的进展的全球报告:33个肝炎消除概况的调查结果
Lindsey Hiebert-Suwondo1, Jana Manning1, Rania A Tohme2
1Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.
大多数国家都在朝着消除乙型肝炎的方向前进,许多国家实现了儿童疫苗接种目标. 然而,获得检测和治疗仍然是一个重大障碍,特别是在低收入国家.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 全球卫生政策 全球卫生政策
背景情况:
- 消除病毒性肝炎是全球卫生优先事项.
- 全球消除肝炎联盟制定了国家消除肝炎概况,以跟踪进展.
- 这些概况评估了针对病毒性肝炎消除的国家数据,政策和方案的制定.
研究的目的:
- 评估全球乙型肝炎消除工作的情况.
- 确定在实现世界卫生组织 (WHO) 2025年目标方面取得的进展和挑战.
- 为消除乙型肝炎的国家规划和资源动员提供指导.
主要方法:
- 分析33个国家和地区的国家肝炎消除概况.
- 评估与世卫组织儿童HBsAg患病率的临时目标相比的进展情况.
- 评估B型肝炎的普遍出生剂量疫苗接种政策.
- 对获得乙型肝炎检测和治疗服务的审查.
主要成果:
- 73%的分析国家实现了2025年世卫组织在儿童中HBsAg流行率 (<0.5%) 的临时目标.
- 67%的人拥有普遍的乙型肝炎出生剂量疫苗接种政策.
- 获得检测和治疗的机会不足以达到最佳水平,特别是在低收入和中等收入国家.
- 只有一个高收入国家实现了世卫组织2025年诊断覆盖率60%的目标.
- 没有一个国家达到世卫组织2025年治疗目标 (≥50%的乙型肝炎患者接受治疗).
结论:
- 在控制乙型肝炎方面取得了重大进展,特别是在儿童疫苗接种方面.
- 在实现广泛的测试和治疗准入方面,仍然存在重大挑战.
- 有针对性的干预和资源动员对于加速全球消除乙型肝炎至关重要.
更多相关视频
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
相关概念视频
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drug Elimination: Non-Renal Routes
Hepatic Drug Excretion: Influencing Factors
